These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 19027463)

  • 1. Non-small cell lung cancer in the elderly: defining treatment options.
    Vora N; Reckamp KL
    Semin Oncol; 2008 Dec; 35(6):590-6. PubMed ID: 19027463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elderly patients with advanced NSCLC: The value of geriatric evaluation and the feasibility of CGA alternatives in predicting chemotherapy toxicity.
    Almodovar T; Teixeira E; Barroso A; Soares M; Queiroga HJ; Cavaco-Silva J; Barata F
    Pulmonology; 2019; 25(1):40-50. PubMed ID: 30266308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced non-small-cell lung cancer in the elderly: results of an international expert panel.
    Gridelli C; Aapro M; Ardizzoni A; Balducci L; De Marinis F; Kelly K; Le Chevalier T; Manegold C; Perrone F; Rosell R; Shepherd F; De Petris L; Di Maio M; Langer C
    J Clin Oncol; 2005 May; 23(13):3125-37. PubMed ID: 15860872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical treatment of advanced non-small cell lung cancer in elderly patients: a review of the role of chemotherapy and targeted agents.
    Meoni G; Cecere FL; Lucherini E; Di Costanzo F
    J Geriatr Oncol; 2013 Jul; 4(3):282-90. PubMed ID: 24070465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy in elderly patients with advanced lung cancer. Part II: Treatment of non-small cell lung cancer (NSCLC).
    Honecker F; Wedding U; Bokemeyer C;
    Onkologie; 2004 Dec; 27(6):583-8. PubMed ID: 15591721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Present trends in the treatment of advanced non small-cell lung cancer.
    Parvez T; Allam AR; Iskandrani A; Khan MA
    J Coll Physicians Surg Pak; 2003 Aug; 13(8):483-90. PubMed ID: 12921691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy in elderly patients with nonsmall cell lung cancer.
    Veluswamy RR; Levy B; Wisnivesky JP
    Curr Opin Pulm Med; 2016 Jul; 22(4):336-43. PubMed ID: 27100301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-comparative monotherapy trials of ZD1839 in previously treated non-small cell lung cancer patients.
    Herbst RS
    Semin Oncol; 2003 Feb; 30(1 Suppl 1):30-8. PubMed ID: 12644982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced non-small-cell lung cancer in the elderly.
    Vamvakas L; Saloustros E; Karampeazis A; Georgoulias V
    Clin Lung Cancer; 2009 May; 10(3):158-67. PubMed ID: 19443335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin-based chemotherapy in elderly patients with advanced stage (IIIB and IV) non-small cell lung cancer patients.
    Ozkaya S; Findik S; Atici AG; Dirica A
    Neoplasma; 2011; 58(4):348-51. PubMed ID: 21520993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
    Greenhalgh J; Dwan K; Boland A; Bates V; Vecchio F; Dundar Y; Jain P; Green JA
    Cochrane Database Syst Rev; 2016 May; (5):CD010383. PubMed ID: 27223332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial.
    Perrone F; Gallo C; Gridelli C
    J Natl Cancer Inst; 2002 Jul; 94(13):1029-30; author reply 1030-1. PubMed ID: 12096088
    [No Abstract]   [Full Text] [Related]  

  • 13. Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer.
    Vasconcellos VF; Marta GN; da Silva EM; Gois AF; de Castria TB; Riera R
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD009256. PubMed ID: 31930743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neglected and underrepresented subpopulations: elderly and performance status 2 patients with advanced-stage non-small-cell lung cancer.
    Langer CJ
    Clin Lung Cancer; 2006 May; 7 Suppl 4():S126-37. PubMed ID: 16764753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increasing underrepresentation of elderly patients with advanced colorectal or non-small-cell lung cancer in chemotherapy trials.
    Jennens RR; Giles GG; Fox RM
    Intern Med J; 2006 Apr; 36(4):216-20. PubMed ID: 16640737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Older age, poor performance status and major comorbidities: how to treat high-risk patients with advanced nonsmall cell lung cancer.
    Aggarwal C; Langer CJ
    Curr Opin Oncol; 2012 Mar; 24(2):130-6. PubMed ID: 22314616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung cancer in the elderly.
    Gridelli C; Langer C; Maione P; Rossi A; Schild SE
    J Clin Oncol; 2007 May; 25(14):1898-907. PubMed ID: 17488989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation.
    Greenhalgh J; Bagust A; Boland A; Dwan K; Beale S; Hockenhull J; Proudlove C; Dundar Y; Richardson M; Dickson R; Mullard A; Marshall E
    Health Technol Assess; 2015 Jun; 19(47):1-134. PubMed ID: 26134145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of locally advanced non-small cell lung cancer in the elderly.
    Gridelli C; Maione P; Rossi A; Ciardiello F; Raben D
    Curr Opin Oncol; 2005 Mar; 17(2):130-4. PubMed ID: 15725917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of lung cancer in the elderly. Part I: non-small cell lung cancer.
    Weinmann M; Jeremic B; Toomes H; Friedel G; Bamberg M
    Lung Cancer; 2003 Mar; 39(3):233-53. PubMed ID: 12609562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.